573 related articles for article (PubMed ID: 29518896)
21. A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression.
Blasco H; Patin F; Descat A; Garçon G; Corcia P; Gelé P; Lenglet T; Bede P; Meininger V; Devos D; Gossens JF; Pradat PF
PLoS One; 2018; 13(6):e0198116. PubMed ID: 29870556
[TBL] [Abstract][Full Text] [Related]
22. Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer.
Sun L; Tu H; Chen T; Yuan Q; Liu J; Dong N; Yuan Y
Sci Rep; 2017 Sep; 7(1):11621. PubMed ID: 28912586
[TBL] [Abstract][Full Text] [Related]
23. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
24. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.
Juan Cai W; Yin L; Kang Q; Chen Zeng Z; Liang Wang S; Cheng J
Sci Rep; 2017 Mar; 7():43536. PubMed ID: 28251999
[TBL] [Abstract][Full Text] [Related]
25. Orange juice affects acylcarnitine metabolism in healthy volunteers as revealed by a mass-spectrometry based metabolomics approach.
Moreira V; Brasili E; Fiamoncini J; Marini F; Miccheli A; Daniel H; Lee JJH; Hassimotto NMA; Lajolo FM
Food Res Int; 2018 May; 107():346-352. PubMed ID: 29580494
[TBL] [Abstract][Full Text] [Related]
26. Deconstructing the pig sex metabolome: Targeted metabolomics in heavy pigs revealed sexual dimorphisms in plasma biomarkers and metabolic pathways.
Bovo S; Mazzoni G; Calò DG; Galimberti G; Fanelli F; Mezzullo M; Schiavo G; Scotti E; Manisi A; Samoré AB; Bertolini F; Trevisi P; Bosi P; Dall'Olio S; Pagotto U; Fontanesi L
J Anim Sci; 2015 Dec; 93(12):5681-93. PubMed ID: 26641177
[TBL] [Abstract][Full Text] [Related]
27. Determinants of the urinary and serum metabolome in children from six European populations.
Lau CE; Siskos AP; Maitre L; Robinson O; Athersuch TJ; Want EJ; Urquiza J; Casas M; Vafeiadi M; Roumeliotaki T; McEachan RRC; Azad R; Haug LS; Meltzer HM; Andrusaityte S; Petraviciene I; Grazuleviciene R; Thomsen C; Wright J; Slama R; Chatzi L; Vrijheid M; Keun HC; Coen M
BMC Med; 2018 Nov; 16(1):202. PubMed ID: 30404627
[TBL] [Abstract][Full Text] [Related]
28. Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.
Kuligowski J; Sanjuan-Herráez D; Vázquez-Sánchez MA; Brunet-Vega A; Pericay C; Ramírez-Lázaro MJ; Lario S; Gombau L; Junquera F; Calvet X; Quintás G
J Proteome Res; 2016 Aug; 15(8):2729-38. PubMed ID: 27384260
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
30. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
31. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
[TBL] [Abstract][Full Text] [Related]
33. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.
Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ
World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098
[TBL] [Abstract][Full Text] [Related]
34. Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia.
Kumar S; Kumari N; Mittal RD; Ghoshal UC
Gastric Cancer; 2016 Jul; 19(3):808-16. PubMed ID: 26486507
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of leptin as marker for patients at high risk of gastric cancer.
Capelle LG; de Vries AC; Haringsma J; Steyerberg EW; Looman CW; Nagtzaam NM; van Dekken H; ter Borg F; de Vries RA; Kuipers EJ
Helicobacter; 2009 Dec; 14(6):596-604. PubMed ID: 19889078
[TBL] [Abstract][Full Text] [Related]
36. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
38. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population.
Sun L; Tu H; Liu J; Gong Y; Xu Q; Jing J; Dong N; Yuan Y
Scand J Gastroenterol; 2014 Oct; 49(10):1164-72. PubMed ID: 25157583
[TBL] [Abstract][Full Text] [Related]
40. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
